# Mycapssa

NDC: 10122-550
Generic name: Octreotide
Labeler / Manufacturer: Chiesi USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE, DELAYED RELEASE
Routes: ORAL
Marketing started: 20200706

FDA application: NDA208232

## Active ingredients

- OCTREOTIDE: 20 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"10122-550"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=10122-550
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=58d80bc6-bdfb-4908-93e7-aace447c8d1a